A LITTLE MORE WORLD. A LOT LESS EFFORT.111 editorial sources OCTOBER 23, 2026
🇺🇸 United States / English

The world, in perspective.

Fresh headlines from around the world. Gaming, politics, technology and everything in between.

Auto refresh · 60 sec
Science🇺🇸 US
ScienceDailyEN

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

World🇧🇷 BR
G1PT

Incêndio atinge fábrica de pães no Distrito Industrial, em João Pessoa; VÍDEO

Incêndio é registrado no Distrito Industrial, em João Pessoa Um incêndio de grandes proporções foi registrado em uma fábrica de panificação no Distrito Industrial, em João Pessoa, na tarde desta quinta-feira (22). A informação foi confirmada pelo Corpo de Bombeiros. ✅ Clique aqui para seguir o canal do g1 PB no WhatsApp De acordo com informações apuradas pel

World🇳🇬 NG
PunchEN

Edo seeks resolution to BEDC industrial dispute

The Edo State Government is seeking a resolution to the industrial dispute between electricity workers and the BEDC, which has left the state in darkness. Read More: https://punchng.com/edo-seeks-resolution-to-bedc-industrial-dispute/

Entertainment🇺🇸 US
DeadlineEN

Russell Brand Trial: Witnesses Say Their Friend Was “Extremely Distressed” After Alleged Anal Rape

Editor’s note: This story contains details of alleged sexual offenses that some readers may find distressing. Multiple witnesses in the Russell Brand trial have claimed that their friend was in physical pain and “extremely distressed” after she was allegedly anally raped by the Despicable Me star in 2009. On the ninth day of Brand’s trial […]

Health🇬🇧 GB
The GuardianEN

Controversial US-backed vaccine trial in African newborns halted

<p>Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’</p><p>The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.</p><p>It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schal

Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.